免疫细胞中PD-L1表达对口咽鳞状细胞癌患者放疗反应的影响
本研究对92例接受放疗的口咽鳞状细胞癌患者进行免疫组化染色,检测p16及肿瘤免疫相关蛋白表达。结果发现,浸润CD8阳性细胞丰富者总生存率显著更优(p=0.026),肿瘤细胞PD-L1高表达(TC 1-3)者OS(p=0.019)和PFS(p=0.032)均更好,浸润免疫细胞PD-L1高表达(IC 3)者OS(p=0.009)和PFS(p=0.011)显著更优。结论认为,除肿瘤p16表达外,肿瘤细胞和免疫细胞PD-L1表达可用于预测口咽鳞状细胞癌放疗反应。
要点
- 92例口咽鳞状细胞癌放疗患者中,浸润CD8阳性细胞丰富者总生存率显著优于CD8阳性细胞较少者(p=0.026)。
- 肿瘤细胞PD-L1高表达(TC 1-3)者OS(p=0.019)和PFS(p=0.032)均优于肿瘤细胞PD-L1低表达(TC 0)者。
- 浸润免疫细胞PD-L1高表达(IC 3)者OS(p=0.009)和PFS(p=0.011)显著优于PD-L1低表达(IC 0-2)者。
核心结论
- 除肿瘤p16表达外,肿瘤细胞和浸润免疫细胞的PD-L1表达可用于预测口咽鳞状细胞癌对放疗的反应。
研究设计与样本
- 对92例接受放疗的口咽鳞状细胞癌患者进行免疫组化染色,检测p16及肿瘤免疫相关蛋白表达。
主要发现
- 浸润CD8阳性细胞丰富者的总生存率显著优于CD8阳性细胞较少者(p=0.026)。
- 肿瘤细胞PD-L1高表达(TC 1-3)者的OS(p=0.019)和PFS(p=0.032)均优于肿瘤细胞PD-L1低表达(TC 0)者。
- 浸润免疫细胞PD-L1高表达(IC 3)者的OS(p=0.009)和PFS(p=0.011)显著优于PD-L1低表达(IC 0-2)者。
- p16阴性且IC 3者的OS与p16阳性且IC 0-2者相似。
- p16阳性肿瘤的CD8阳性细胞浸润和肿瘤细胞PD-L1表达均显著高于p16阴性肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To investigate influences of proteins involved with tumor immunity on outcomes of radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC). MATERIAL AND METHODS: We performed immunohistochemical staining to examine expressions of p16 and proteins involved with tumor immunity in 92 OPSCC patients treated with radiotherapy. RESULTS: Patients with abundant infiltrating CD8-positive cells had the significantly better overall survival (OS) rate than patients with fewer CD8-positive cells (p = 0.026). Patients with higher PD-L1 expression in tumor cells (TC 1-3) had a better outcome than those with low PD-L1 expression in tumor cells (TC 0) for both OS (p = 0.019) and progression-free survival (PFS) rate (p = 0.032). Patients with high PD-L1 expression in infiltrating immune cells (IC 3) showed significantly better OS (p = 0.009) and PFS (p = 0.011) than those with low PD-L1 expression (IC 0-2). Patients with p16-negative and IC 3 showed similar OS to patients with p16-positive and IC 0-2. P16-positive tumors had a significantly higher CD8-positive cell infiltration and PD-L1 expression in tumor cells than p16-negative tumors. CONCLUSIONS: In addition to tumor p16 expression, PD-L1 expression in TC and IC can be useful for predicting the response of OPSCC to radiotherapy.
引用
- Fukushima Y, Someya M, Nakata K, et al. Influence of PD-L1 expression in immune cells on the response to radiation therapy in patients with oropharyngeal squamous cell carcinoma. Radiother Oncol. 2018. PMID: 30249348. doi:10.1016/j.radonc.2018.08.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。